Posted by Michael Wonder on 21 Sep 2021
NHS patients gain access to COVID-19 treatment Ronapreve
21 September 2021 - The UK has secured supply of Ronapreve, a new COVID-19 therapeutic developed by Regeneron and Roche that combines two monoclonal antibodies – casirivimab and imdevimab.
The drug is administered either by injection or infusion, acting at the lining of the respiratory system where it binds to the SARS-CoV-2 virus and prevents it from gaining access to cells.
